Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) fell 14.7% during trading on Tuesday . The company traded as low as C$0.15 and last traded at C$0.15. 266,015 shares changed hands during mid-day trading, a decline of 10% from the average session volume of 294,436 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Trading Down 9.1 %
The firm has a market capitalization of C$24.33 million, a P/E ratio of -4.63 and a beta of 0.39. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The firm’s 50-day simple moving average is C$0.11 and its 200-day simple moving average is C$0.13.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- How to trade penny stocks: A step-by-step guide
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
